News Conference News TVT 2023 ‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients Michael O'Riordan June 09, 2023
News Features TVT 2022 Minorities, Poorer Patients Missing Out on Structural Heart Care Michael O'Riordan June 15, 2022
News Conference News TVT 2022 No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest Michael O'Riordan June 09, 2022
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Conference News TVT 2020 Newer TAVR Devices Reassure in Failed Surgical Valves Shelley Wood June 20, 2020
News Conference News TVT 2019 Real-world Stroke With TAVR: TVT Registry Insights Rekindle Cerebral Protection Debate Shelley Wood June 13, 2019
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Conference News TVT 2017 Reacting to REPRISE III: Enthusiasm, Explanations, and Caveats for the Lotus Pivotal TAVR Trial Shelley Wood June 16, 2017
News Conference News TVT 2017 Embolic Protection During TAVR Reduces Stroke Risk, Single-Center Study Shows Michael O'Riordan June 15, 2017
News Conference News TVT 2017 Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms Shelley Wood June 15, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Conference News TVT 2016 When Is Sick Too Sick for TAVR? Physicians Grapple With Identifying Futile Care Michael O'Riordan June 20, 2016
News Conference News TVT 2016 What TAVR Needs Next . . . and What It’s Getting Shelley Wood June 17, 2016